Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions.

Abstract:

PURPOSE OF REVIEW:Optimal management of anxiety and mood disorders in patients with systemic lupus erythematosus (SLE) is limited by an incomplete understanding of their pathophysiology and a lack of treatment guidelines. This review aims to critically synthesize recent literature on these conditions in adults with SLE, focusing on their etiology, assessment, and management. RECENT FINDINGS:Along with psychosocial factors, there is growing evidence for a bidirectional interaction between inflammatory pathways and SLE-associated anxiety and mood disorders. Direct immune-mediated mechanisms via autoantibodies may also play a role in some cases. With a growing number of tools used in SLE for the assessment of these conditions, the search continues for the ideal instrument to use in all future investigations to allow comparisons across studies. There is data supporting psychological interventions, but a dearth of literature on pharmacotherapy for the treatment of anxiety and mood disorders in SLE. There is a clear need for further research in anxiety and mood disorders in SLE, particularly with respect to diagnostic tools and medications, which could inform much-needed updates to current guidelines.

journal_name

Curr Rheumatol Rep

authors

Tisseverasinghe A,Peschken C,Hitchon C

doi

10.1007/s11926-018-0797-2

subject

Has Abstract

pub_date

2018-11-12 00:00:00

pages

85

issue

12

eissn

1523-3774

issn

1534-6307

pii

10.1007/s11926-018-0797-2

journal_volume

20

pub_type

杂志文章,评审
  • Rheumatoid arthritis genetics: 2009 update.

    abstract::Recent human genetic discoveries have increased our understanding of rheumatoid arthritis (RA) susceptibility. Genome-wide association studies have expanded the number of validated RA risk loci beyond HLA-DRB1 "shared epitope" alleles to include additional major histocompatibility complex (MHC) risk alleles and more t...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-009-0050-0

    authors: Plenge RM

    更新日期:2009-10-01 00:00:00

  • The immune system, the skin, and childhood rheumatic disease.

    abstract::As the body's largest organ and first line of defense against the environment, the skin plays a vital role in host immune defense. In addition to its function as a physical barrier, the skin contains an active immune surveillance network and can mount highly specific responses to eliminate invading organisms. In this ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-010-0158-2

    authors: Fuhlbrigge RC,Chaiban R

    更新日期:2011-04-01 00:00:00

  • Dendritic cells: novel players in fibrosis and scleroderma.

    abstract::Dendritic cells are professional antigen-presenting cells that are most studied for their function in mediating T-cell tolerance and T-cell activation. In addition, recent evidence indicates that dendritic cells can regulate the vasculature and function of fibroblast-type cells. The potential contribution of dendritic...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-011-0215-5

    authors: Lu TT

    更新日期:2012-02-01 00:00:00

  • The perspective on psoriatic arthritis in Asia.

    abstract::There is a wide variation in the prevalence, incidence, and clinical manifestation of psoriatic arthritis (PsA) across countries due to genetic and environmental factors. Data on PsA in Asia are limited and come from small cross-sectional studies. The burden of PsA in Asia is high, including poor physical functioning,...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-011-0183-9

    authors: Leung YY,Tam LS,Li EK

    更新日期:2011-08-01 00:00:00

  • New developments in the epidemiology and genetics of gout.

    abstract::The prevalence of gout appears to be rapidly increasing worldwide and is no longer a disorder suffered primarily by over-fed alcohol consumers. Emerging risk factors include longevity, metabolic syndrome, and new classes of pharmacologic agents. In some ethnic populations, no obvious risk factors can explain the high ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-996-0028-0

    authors: Zaka R,Williams CJ

    更新日期:2006-06-01 00:00:00

  • The clinical laboratory evaluation of the patient with noninflammatory myopathy.

    abstract::The investigations used to diagnose an inflammatory muscle disease include history and physical examination, evaluation of serum levels of enzymes derived from skeletal muscle, electromyography, magnetic resonance imaging, and muscle histology. The evaluation of patients who may have noninflammatory myopathy includes,...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-001-0035-0

    authors: Wortmann RL,Vladutiu GD

    更新日期:2001-08-01 00:00:00

  • Systemic manifestations in localized scleroderma.

    abstract::In this paper, the various systemic manifestations reported in localized scleroderma, their incidence, their relationship with systemic sclerosis, and their relationship with other autoimmune or connective tissue diseases will be analyzed. ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-004-0020-5

    authors: Zulian F

    更新日期:2004-12-01 00:00:00

  • Hypocomplementemic urticarial vasculitis syndrome.

    abstract::Hypocomplementemic urticarial vasculitis syndrome (HUVS) is an uncommon immune complex-mediated entity characterized by urticaria with persistent acquired hypocomplementemia. First described in 1973, HUVS is associated with several systemic findings including leukocytoclastic vasculitis, severe angioedema, laryngeal e...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-009-0060-y

    authors: Jara LJ,Navarro C,Medina G,Vera-Lastra O,Saavedra MA

    更新日期:2009-12-01 00:00:00

  • Critical appraisal of classification criteria for vasculitides.

    abstract::The vasculitides are a group of protean diseases, some of which are caused by conditions including infections, other autoimmune diseases, or neoplasias. They are a challenge to the clinician, in terms of both diagnosis and therapy. No diagnostic criteria exist, although a multinational effort to develop them is in pro...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-014-0422-y

    authors: Flores-Suárez LF,Contreras-Rodríguez Fde J

    更新日期:2014-06-01 00:00:00

  • Perioperative infection in the patient with rheumatic disease.

    abstract::The risk of infection accompanies the benefits of surgery. Immunomodulatory chronic illnesses may increase the risk of surgical infections. Surgical patients with rheumatologic illness need close preoperative assessment regarding their infection risks (fixed and modifiable), which vary on the basis of the proposed pro...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-013-0379-2

    authors: Miller AO,Brause BD

    更新日期:2013-12-01 00:00:00

  • Lung Transplantation in Patients With Systemic Sclerosis.

    abstract:PURPOSE OF REVIEW:The purpose of this study was to highlight recent findings on evaluation for lung transplantation and outcomes after transplantation in patients with systemic sclerosis (scleroderma). RECENT FINDINGS:The recognition that extra-pulmonary disease manifestations can seriously compromise post-transplant ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-017-0650-z

    authors: Shah RJ,Boin F

    更新日期:2017-05-01 00:00:00

  • Gene therapies for osteoarthritis.

    abstract::Osteoarthritis (OA) is a major health problem in urgent need of better treatment. Gene therapy offers to meet this need. Of the different strategies for using gene therapy in OA, local gene transfer to synovium is in the most advanced stage of development. Local gene transfer brings several advantages, including a foc...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-004-0081-5

    authors: Evans CH

    更新日期:2004-02-01 00:00:00

  • Gout and organ transplantation.

    abstract::Acute and chronic gout are common complications following organ transplantation. Risk factors include those shared with the general population (eg, diuretic use) and transplant-specific risk factors (eg, cyclosporine). Clinical features of gout are similar to those seen in the general population, although tophi may be...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-012-0235-9

    authors: Stamp LK,Chapman PT

    更新日期:2012-04-01 00:00:00

  • The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.

    abstract::TNF-blocking biologics have revolutionized the care of patients with spondyloarthritis, a group of clinically overlapping conditions that includes ankylosing spondylitis and psoriatic arthritis. However, incomplete response rates speak to the need for alternative therapeutic approaches. Over the last decade, animal mo...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-016-0585-9

    authors: Smith JA

    更新日期:2016-06-01 00:00:00

  • Clinical update on teriparatide.

    abstract::Teriparatide (recombinant human parathyroid hormone ) is an anabolic agent approved for the treatment of patients at high risk for fracture. The Fracture Prevention Trial administered teriparatide to treatment-naïve patients, leading to its US Food and Drug Administration approval in 2002. Clinical trial data using an...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-009-0023-3

    authors: File E,Deal C

    更新日期:2009-07-01 00:00:00

  • Neurologic manifestations of the antiphospholipid syndrome.

    abstract::Antiphospholipid syndrome is an important cause of neurologic morbidity. The clinical criteria for antiphospholipid syndrome include only cerebrovascular arterial and venous thrombosis, but many other neurologic manifestations have been associated with antiphospholipid antibodies (aPL). This review discusses the role ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-007-0004-3

    authors: Roldan JF,Brey RL

    更新日期:2007-05-01 00:00:00

  • Genetics of hyperuricemia and gout: implications for the present and future.

    abstract::Gout is the most common inflammatory arthropathy and occurs in the setting of elevated serum urate levels. Gout is also known to be associated with multiple comorbidities including cardiovascular disease and the metabolic syndrome. Recent advances in research have increased our understanding and improved our knowledge...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-012-0309-8

    authors: George RL,Keenan RT

    更新日期:2013-02-01 00:00:00

  • Familial autoimmunity and the idiopathic inflammatory myopathies.

    abstract::Many lines of evidence suggest that autoimmune diseases result from chronic immune activation following environmental exposures in genetically susceptible individuals. A genetic basis for autoimmunity is supported by twin and family studies, candidate gene investigations, animal models, and whole genome microsatellite...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-000-0080-0

    authors: Shamim EA,Miller FW

    更新日期:2000-06-01 00:00:00

  • Premenopausal bone health assessment.

    abstract::The World Health Organization criteria for classification of bone mineral density (BMD) cannot be applied to premenopausal women because the relationship between BMD and fracture risk is not the same as in postmenopausal women. Approximately 2.5% of premenopausal women have BMD that is more than 2.0 standard deviation...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-005-0008-9

    authors: Lewiecki EM

    更新日期:2005-03-01 00:00:00

  • Erosive osteoarthritis: presentation, clinical pearls, and therapy.

    abstract::Erosive osteoarthritis (OA) is a subcategory of OA in which destructive changes occur in the joints, probably as a result of a combination of inflammatory inciters and phenomena. The major changes occur in the distal and proximal interphalangeal joints, root joints of the thumb, and less commonly other hand and centri...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-001-0062-x

    authors: Ehrlich GE

    更新日期:2001-12-01 00:00:00

  • AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.

    abstract::Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) is the first-ever international network created to design and conduct large-scale, multicenter clinical trials and research in persistently antiphospholipid antibody (aPL)-positive patients. Since its inception in 2010, th...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-016-0611-y

    authors: Barbhaiya M,Andrade D,Erkan D,APS ACTION.

    更新日期:2016-10-01 00:00:00

  • Molecular pathogenesis of skin fibrosis: insight from animal models.

    abstract::Skin fibrosis occurs in a variety of human diseases, most notably systemic sclerosis (SSc). The end stage of scleroderma in human skin consists of excess collagen deposition in the dermis with loss of adnexal structures and associated adipose tissue. The initiating factors for this process and the early stages are bel...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-009-0080-7

    authors: Smith GP,Chan ES

    更新日期:2010-02-01 00:00:00

  • Novel Insights into Osteoarthritis Joint Pathology from Studies in Mice.

    abstract::Osteoarthritis causes tremendous individual suffering and staggering societal costs, but due to our limited understanding of the underlying molecular and cellular mechanisms, our avenues for treating this disease are very restricted. Recent years have seen a drastic increase in the use of genetically modified mice to ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-015-0524-1

    authors: Moon PM,Beier F

    更新日期:2015-08-01 00:00:00

  • Update on biomarkers in psoriatic arthritis.

    abstract::Biomarkers in psoriatic arthritis (PsA) may serve as surrogate end points for disease outcome and can provide insights into disease susceptibility and natural history. Biomarkers could relate to diagnosis, pathogenesis, prognosis, therapeutic response, and comorbidities. The "felt need" is, however, in the development...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-010-0107-0

    authors: Chandran V,Gladman DD

    更新日期:2010-08-01 00:00:00

  • Update on the management of the pregnant patient with antiphospholipid antibody.

    abstract::Management of the pregnant patient with antiphospholipid antibody (aPL) is reviewed, with emphasis on recent randomized controlled clinical trials. These support the use of subcutaneous heparin and low dose aspirin, current standard therapy for women with aPL and a history of fetal loss. Prednisone is rarely used due ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-001-0021-6

    authors: Sammaritano LR

    更新日期:2001-06-01 00:00:00

  • Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.

    abstract:PURPOSE OF REVIEW:Ankylosing spondylitis (AS) was historically seen as a predominantly male disease. However, more recent data showed a more homogenous sex prevalence. Unfortunately, in many studies in axial spondyloarthritis (axSpA), the number of women included is low and the analyses are often not stratified for gen...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-018-0744-2

    authors: Rusman T,van Vollenhoven RF,van der Horst-Bruinsma IE

    更新日期:2018-05-12 00:00:00

  • Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis.

    abstract::Transforming growth factor-beta (TGF beta) plays a critical role in the development of tissue fibrosis. Its expression is consistently elevated in affected organs and correlates with increased extracellular matrix deposition. During the last few years, tremendous progress has been made in understanding the molecular a...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-002-0010-4

    authors: Verrecchia F,Mauviel A

    更新日期:2002-04-01 00:00:00

  • The role of bone metabolism in osteoarthritis.

    abstract::Bone is not structurally normal in osteoarthritis (OA). Periarticular bone in OA has increased turnover, decreased bone mineral content and stiffness, and decreased trabecular numbers. The increased turnover of collagen, in particular, may affect the biomechanical competence of bone and is driven by a number of proces...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-003-0078-5

    authors: Hunter DJ,Spector TD

    更新日期:2003-02-01 00:00:00

  • Use of biomarkers in the management of children with lupus.

    abstract::Childhood systemic lupus erythematosus (SLE) is known to have a worse prognosis than adult-onset disease, and monitoring and treatment of the disease are still a challenge. Thus, there is an urgent need for highly reliable, non-invasive biomarkers for early detection of relapses, to avoid long-term complications and t...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-012-0312-0

    authors: Binder E,Edelbauer M

    更新日期:2013-03-01 00:00:00

  • Pitfalls and opportunities in measuring patient outcomes in lupus.

    abstract::Health outcomes and their measures used as end points in systemic lupus erythematosus (SLE) patient care and clinical trials have been varied and are still evolving. Although significant reductions in morbidity and mortality in SLE have been achieved, the medications approved for SLE have remained the same during the ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-010-0105-2

    authors: Jolly M

    更新日期:2010-08-01 00:00:00